Section Arrow
JNJ.NYSE
- Johnson & Johnson
Quotes are at least 15-min delayed:2026/03/09 23:28 EDT
Regular Hours
Last
 242.59
+2.19 (+0.91%)
Day High 
244.09 
Prev. Close
240.4 
1-M High
251.71 
Volume 
7.84M 
Bid
242.04
Ask
242.5
Day Low
240.04 
Open
240.87 
1-M Low
235.43 
Market Cap 
579.34B 
Currency 美元 
P/E 21.64 
%Yield 2.14 
10-SMA 244.98 
20-SMA 243.67 
50-SMA 227.39 
52-W High 251.71 
52-W Low 141.5 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
11.03/12.36
Enterprise Value
618.78B
Balance Sheet
Book Value Per Share
33.84
Cash Flow
Cash Flow Yield
0.04
Income Statement
Total Revenue
94.19B
Operating Revenue Per Share
40.94
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
MDCXMedicus Pharma Ltd0.52+0.1348+34.99%-- 
PFEPfizer26.81-0.24-0.89%19.84PE
NVONovo-Nordisk A/S39.78+1.2+3.11%10.75PE
BMYBristol-Myers Squibb Co60.63+0.34+0.56%17.41PE
MRKMerck & Co117.11+1.32+1.14%15.9PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.